Results from PROCEDE 500, a clinical utility study with the Prolaris test, demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer.
Combination vaccine significantly improves overall survival in pancreatic cancer, compared with single-component vaccine.
Report features 76 studies; highlights new approaches to cancer care and new treatments.
Surveillance should be planned according to presumed risk of recurrence and patients' functional status.
A research team from the NCI and ASCO presented a summary of best practices and strategies for future research in a co-sponsored symposium.
Improved education, support for tobacco control policies, and more research were recommended by the American Society of Clinical Oncology.
In women with previously treated metastatic breast cancer who shared certain traits, treatment with the newer chemotherapy agent eribulin mesylate had increased benefit over capecitabine.
Irregularities in the expression of the HER2 growth-factor gene have been found in 14 different advanced solid tumors.
A new test may help identify which patients with newly diagnosed glioblastoma are more likely to benefit from bevacizumab.
American Society of Clinical Oncology updates 2006 guideline with minor revisions, including updates to the area of fertility preservation in children and adults with cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|